Browse by Speaker

Type here to filter the list

H
H.A. Bemelmans, Marc

Department of Surgery, Maastricht University Medical Center+, Maastricht
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Marc H.A. Bemelmans
Favorite
Haase, Kerstin

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Kerstin Haase
Favorite
Haas, Rick

NKI-AvL
Mentorship Session 8: How to Get Involved in CTOS
Rick Haas
Favorite
Haber, Michelle

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Michelle Haber
Favorite
Hackbarth, Donald

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Donald Hackbarth
Favorite
Haddock, Michael

Mayo Clinic
Paper 39 - PENCIL BEAM SCANNING PROTON RADIOTHERAPY FOR SACRAL CHORDOMAS: THE MAYO CLINIC EXPERIENCE
Michael Haddock
Favorite
Haddox, Candace

Dana-Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Candace Haddox
Favorite
Hadzic, Armin

Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Armin Hadzic
Favorite
Hames-Fathi, Shadi

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Shadi Hames-Fathi
Favorite
Hamm, Jeremy

BC Cancer-Cancer Surveillance & Outcomes
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Jeremy Hamm
Favorite
Hanna, Diana

USC Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Diana Hanna
Favorite
Hannay, Jonathan

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Jonathan Hannay
Favorite
Harrington, Kevin

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Kevin Harrington
Favorite
Harrison, Douglas

University of Texas MD Anderson Cancer Center
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Douglas Harrison
Favorite
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Douglas Harrison
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Douglas Harrison
Favorite
Hart, Jesse

Department of Pathology, Lifespan Laboratories, Rhode Island Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jesse Hart
Favorite
Hayashi, Masanori

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Masanori Hayashi
Favorite
Hayden, James

Oregon Health & Science University
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
James Hayden
Favorite
Hayes, Andrew

Royal Marsden Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Andrew Hayes
Favorite
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Andrew Hayes
Favorite
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Andrew Hayes
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Andrew Hayes
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Andrew Hayes
Favorite
Hayes-Jordan, Andrea

Lineberger Comprehensive Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Andrea Hayes-Jordan
Favorite
Healey, John

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
John Healey
Favorite
Heinrich, Michael

Oregon Health and Science University
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Michael Heinrich
Favorite
Heinzmann, Sebastian

F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Sebastian Heinzmann
Favorite
Heise, Rachel

Weill Cornell Medicine
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Rachel Heise
Favorite
Hendrickson, Peter

Duke Univeristy
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Peter Hendrickson
Favorite
Henning, Jan-Willem

Tom Baker Cancer Centre, University of Calgary
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Jan-Willem Henning
Favorite
Hildebrand, Karys

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Karys Hildebrand
Favorite
Hildebrand, Kurt

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Kurt Hildebrand
Favorite
Hinck, Andrew

Department of Structural Biology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Andrew Hinck
Favorite
Hinckley, John

Battelle Memorial Institute
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
John Hinckley
Favorite
Hindi, Nadia

Fundacion Jimenez Diaz University Hospital/HG Villalba and Instituto de Investigaciones Sanitarias Fundación Jimenez Diaz
Session 1: Telemedicine, Virtual Tumor Boards and Multidisciplinary Care
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Session 13: Epidemiology, Informatics, Population Health, Health Outcomes
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Hiniker, Susan

Stanford University
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Susan Hiniker
Favorite
Hirbe, Angela

Washington University in St. Louis
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Angela Hirbe
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Angela Hirbe
Favorite
Hodson, James

University Hospital Birmingham NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
James Hodson
Favorite
Hohenberger, Peter

University Hospital Essen
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Peter Hohenberger
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Peter Hohenberger
Favorite
Holloway, Caroline

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Caroline Holloway
Favorite
Hompes, Daphne

University Hospitals Gasthuisberg
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Daphne Hompes
Favorite
Hompland, Ivar

Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Ivar Hompland
Favorite
Hong, David

The University of Texas MD Anderson Cancer Center
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
David Hong
Favorite
Honore, Charles

Department of Surgical Oncology, Institut Gustave Roussy
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Charles Honore
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Charles Honore
Favorite
Hornstein, Nicholas

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Nicholas Hornstein
Favorite
Ho, Thanh

Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Thanh Ho
Favorite
Houdek, Matthew

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Matthew Houdek
Favorite
Hoyt, David

University of Utah School of Medicine
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
David Hoyt
Favorite
Huang, Michael

AmMax Biopharma
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Michael Huang
Favorite
Huang, Paul

The Institute for Cancer Research
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Paul Huang
Favorite
Hu, James

University of Southern California Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
James Hu
Favorite
Hunt, Kelly

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Kelly Hunt
Favorite